MedPath

The Intensive Care Infection Score to predict microbial infection and its sequelae in critically ill lung and heart transplant patients.

Conditions
bloodstream infection
Sepsis
10019815
Registration Number
NL-OMON40847
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

All patients above the age of 18 years who will undergo lung or heart transplantation are possibly eligible for this trial.

Exclusion Criteria

N.A.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The likelihood of microbial infection and its invasiveness (bloodstream<br /><br>infection). On the basis of the collected data the investigators, blinded to<br /><br>the study results, will decide after completion of the study whether a proven<br /><br>local infection or not was present from day 0-7 after inclusion. In case of<br /><br>disagreement a third party will be consulted. Source and likelihood of<br /><br>infection will be based on criteria defined at the International Sepsis Forum<br /><br>Consensus Conference.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1.Septic shock. The SIRS criteria according to the ACCP/ SCCM consensus<br /><br>conference criteria of: a body temperature >38º C; a heart rate of >90 beats/<br /><br>min; a respiratory rate > 20 breaths/ min or mechanical ventilation or white<br /><br>cell count (WBC) of < 4.0 x 109/L, will be used. When SIRS and a probable/<br /><br>proven infection or BSI was present, patients will be classified as having<br /><br>sepsis. Shock will be defined by a systolic arterial pressure of < 90 mm Hg or<br /><br>mean arterial pressure (MAP) < 70 mm Hg for at least one hour despite adequate<br /><br>fluid resuscitation or requirement of vasopressor support to maintain MAP, from<br /><br>day 0 to 7.<br /><br>2. All cause mortality refers to day 28 (within ICU of hospital mortality after<br /><br>inclusion and ICU mortality).<br /><br>3. The effect of immunosuppressive medication on the intensive care infection<br /><br>score will be analyzed.</p><br>
© Copyright 2025. All Rights Reserved by MedPath